Molecular genetics of familial hypertrophic cardiomyopathy (FHC)

Journal of Human Genetics

Volumn 48, Issue 2, 2003, Pages 55-64

  Bashyam, Murali D ^a   Savithri, Gorinabele R ^a   Kumar, Murugapiran S ^a   Narasimhan, Calambur ^b   Nallari, Pratibha ^c  

^a CENTRE FOR DNA FINGERPRINTING AND DIAGNOSTICS   (India)

^b CARE HOSPITAL   (India)

^c OSMANIA UNIVERSITY   (India)

Author keywords

Actin; Cardiomyopathy; Hypertrophy; Myocyte disarray; Myosin; Tropomyosin; Troponin

Indexed keywords

PROTEIN;

ACTC GENE; ANGINA PECTORIS; AUTOSOMAL DOMINANT DISORDER; CELL HETEROGENEITY; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE SEVERITY; DYSPNEA; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; GENE LOCUS; GENE MUTATION; GENETIC CODE; GENETIC HETEROGENEITY; GENOTYPE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HUMAN CELL; MOLECULAR GENETICS; MUSCLE CELL; MUSCLE FIBRIL; SARCOMERE; SHORT SURVEY; SUDDEN DEATH; SYMPTOMATOLOGY; TN13 GENE;

CARDIAC MYOSINS; CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; CARRIER PROTEINS; GENETIC HETEROGENEITY; HUMANS; MUSCLE PROTEINS; MUTATION; MYOSIN HEAVY CHAINS; MYOSIN LIGHT CHAINS; PROTEIN KINASES; SARCOMERES; TROPOMYOSIN; TROPONIN T;

ANGINA;

EID: 0037225801     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100380300007     Document Type: Short Survey

References (89)

1. Blair E, Redwood C, de Jesus Oliveira M, Moolman-Smook JC, Brink P, Corfield VA, Ostman-Smith I, Watkins H (2002) Mutations of the light meromyosin domain of the beta-myosin heavy chain rod in hypertrophic cardiomyopathy. Circ Res 90:263-269
2. Bonne G, Carrier L, Bercovici J, Cruaud C, Richard P, Hainque B, Gautel M, Labeit S, James M, Beckmann J (1995) Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet 11:438-440
3. Burton D, Abdulrazzak H, Knott A, Elliott K, Redwood C, Watkins H, Marston S, Ashley C (2002) Two mutations in troponin I that cause hypertrophic cardiomyopathy have contrasting effects on cardiac muscle contractility. Biochem J 362:443-451
4. Chien KR, Zhu H, Knowlton KU, Miller-Hance W, van-Bilsen M, O'Brien TX, Evans SM (1993) Transcriptional regulation during cardiac growth and development. Annu Rev Physiol 55:77-95
5. Cuda G, Fananapazir L, Zhu WS, Sellers JR, Epstein ND (1993) Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy. J Clin Invest 91:2861-2865
6. Cuda G, Mussari A, Concolino D, Costanzo FS, Strisciuglio P (2002) Co-existence of frataxin and cardiac troponin T gene mutations in a child with Friedreich Ataxia and familial hypertrophic cardiomyopathy. Hum Mutat 19:309-310
7. Davies MJ (1984) The current status of myocardial disarray in hyptertrophic cardiomyopathy. Br Heart J 51:361-366
8. Derchi G, Bellone P, Chiarella F, Randazzo M, Zino V, Vecchio C (1992) Plasma levels of atrial natriuretic peptide in hypertrophic cardiomyopathy. Am J Cardiol 70:1502-1504
9. Elliott K, Watkins H, Redwood CS (2000) Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy. J Biol Chem 275:22069-22074
10. Epstein ND, Cohn GM, Cyran F, Fananapazir L (1992) Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908LeuVal mutation and a 403ArgGln mutation. Circulation 86:345-352
11. Fananapazir L, Epstein ND (1994) Genotype-phenotype correlation in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations. Circulation 89:22-32
12. Freiburg A, Gautel M (1996) A molecular map of the interactions between titin and myosin-binding protein-C. Implications for sarcomeric assembly in familial hypertrophic cardiomyopathy. Eur J Biochem 235:317-323
13. Gautel M, Zuffardi O, Freiburg A, Labeit S (1995) Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: a modulator of cardiac contraction? EMBO J 14:1952-1960
14. Geisterfer-Lowrance A, Kass S, Tanigawa G (1990) A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell 62:999-1006
15. Geisterfer-Lowrance AA, Christe M, Conner DA, Ingwall JS, Schoen FJ, Seidman CE, Seidman JG (1996) A mouse model of familial hypertrophic cardiomyopathy. Science 272:731-734
16. Grossman W, Jones D, McLaurin LP (1975) Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 56:56-64
17. Hasegawa K, Fujiwara H, Doyama K, Mukoyama M, Nakao K, Fujiwara T, Imura H, Kawai C (1993) Ventriclar expression of brain natriuretic peptide in hypertrophic cardiomyopathy. Circulation 88:372-380
18. Hasegawa K, Fujiwara H, Koshiji M, Inada T, Ohtani S, Doyama K, Tanaka M, Matsumori A, Fujiwara T, Shirakami G, Hosoda K, Nakao K, Sasayama S (1996) Endothelin-I and its receptor in hypertrophic cardiomyopathy. Hypertension 27:259-264
19. Ho CY, Lever HM, DeSanctis R, Farver CF, Seidman JG, Seidman CE (2000) Homozygous mutation in cardiac troponin T: implications for hypertrophic cardiomyopathy. Circulation 102:1950-1955
20. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M (1994) DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 90:2622-2628
21. James J, Zhang Y, Osinska H, Sanbe A, Klevitsky R, Hewett TE, Robbins J (2000) Transgenic modeling of a cardiac troponin I mutation linked to familial hypertrophic cardiomyopathy. Circ Res 87:805-811
22. Jeschke B, Uhl K, Weist B, Schroder D, Meitinger T, Dohlemann C, Vosberg HP (1998) A high risk phenotype of hypertrophic cardiomyopathy associated with a compound genotype of two mutated β-myosin heavy chain genes. Hum Genet 102:299-304
23. Kai H, Muraishi A, Sugiu Y, Nishi H, Seki Y, Kuwahara F, Kimura A, Kato H, Imaizumi T (1998) Expression of proto-oncogenes and gene mutation of sarcomeric proteins in patients with hypertrophic cardiomyopathy. Circ Res 83:594-601
24. Kimura A, Harada H, Park JE, Nishi H, Satoh M, Takahashi M, Hiroi S, Sasaoka T, Ohbuchi N, Nakamura T, Koyanagi T, Hwang TH, Choo JA, Chung KS, Hasegawa A, Nagai R, Okazaki O, Nakamura H, Matsuzaki M, Sakamoto T, Toshima H, Koga Y, Imaizumi T, Sasazuki T (1997) Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet 16:379-382
25. Kokado H, Shimizu M, Yoshio H, Ino H, Okeie K, Emoto Y, Matsuyama T, Yamaguchi M, Yasuda T, Fujino N, Ito H, Mabuchi H (2000) Clinical features of hypertrophic cardiomyopathy caused by a Lys183 deletion mutation in the cardiac troponin I gene. Circulation 102:6636-6639
26. Komuro I, Kurabayashi M, Takaku F, Yazaki Y (1988) Expression of cellular oncogenes in the myocardium during the developmental stage and pressure-overloaded hypertrophy of the rat heart. Circ Res 62:1075-1079
27. Lang R, Gomes AV, Zhao J, Housmans PR, Miller T, Potter JD (2002) Functional analysis of a troponin I (R145G) mutation associated with familial hypertrophic cardiomyopathy. J Biol Chem 277:11670-11678
28. Lankford EB, Epstein ND, Fananapazir L, Sweeney HL (1996) Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. J Clin Invest 95:1409-1414
29. Lechin M, Quinones MA, Omran A, Hill R, Yu QT, Rakowski H, Wigle D, Liew CC, Sole M, Roberts R, Marian AJ (1995) Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation 92:1808-1812
30. Li D, Czernuszewicz GZ, Gonzalez O, Tapscott T, Karibe A, Durand JB, Brugada R, Hill R, Gregoritch JM, Anderson JL, Quinones M, Bachinski LL, Roberts R (2001) Novel cardiac troponin T mutation as a cause of familial dilated cardiomyopathy. Circulation 104:2188-2193
31. Lin D, Bobkova A, Homsher E, Tobachman L (1996) Altered cardiac troponin T in vitro function in the presence of a mutation implication in familial hypertrophic cardiomyopathy. J Clin Invest 97:2842-2848
32. Marian AJ, Yu QT, Workman R, Greve G, Roberts R (1993) Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 342:1085-1086
33. Marian AJ, Wu YU, Lim DS, McCluggage M, Youker K, Yu QT, Brugada R, DeMayo F, Quinones M, Roberts R (1999) A transgenic rabbit model for human hypertrophic cardiomyopathy. J Clin Invest 104:1683-1692
34. Maron BJ, Roberts WC, Edwards JE, McAllister HA, Foley DD, Epstein SE (1978) Sudden death in patients with hypertrophic cardiomyopathy. Characterization of 26 patients without functional limitation. Am J Cardiol 41:803-810
35. Maron BJ, Roberts WC, Epstein S (1986) Causes of sudden death in competitive athletes. J Am Coll Cardiol 7:204-214
36. Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE (1987) Hypertrophic cardiomyopathy: interrelations of clinical manifestation, pathophysiology and therapy. N Engl J Med 316:780-789
37. Maron BJ, Mitten MJ, Quandt EF, Zipes DP (1998) Competitive athletes with cardiovascular disease: the case of Nicholas Knapp. N Engl J Med 339:1632-1635
38. McConnell BK, Jones KA, Fatkin D, Arroyo LH, Lee RT, Aristizabal O, Turnbull DH, Gergakopoulos D, Kass D, Bond M, Niimura H, Schoen FJ, Conner D, Fischman DA, Seidman CE, Seidman JG, Fischman DH (1999) Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice. J Clin Invest 104:1235-1244
39. Michele DE, Albayya FP, Metzger JM (1999) Direct, convergent hypersensitivity of calcium-activated force generation produced by hypertrophic cardiomyopathy mutant α-tropomyosins in adult cardiac myocytes. Nat Med 5:1413-1417
40. Mogensen J, Klausen IC, Pedersen AK, Egeblad H, Bross P, Kruse TA, Gregersen N, Hansen PS, Baandrup U, Borglum AD (1999) α-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy. J Clin Invest 103:R39-R43
41. Montgomery DE, Tardiff JC, Chandra M (2001) Cardiac troponin T mutations: correlation between the type of mutation and the nature of myofilament dysfunction in transgenic mice. J Physiol 15:583-592
42. Moolman-Smook JC, Mayosi B, Brink P, Corfield VA (1998) Identification of a new missense mutation in MyBP-C associated with hypertrophic cardiomyopathy. J Med Genet 35:253-254
43. Moos C, Feng IM (1990) Effect of C-protein on actomyosin ATPase. Biochim Biophys Acta 632:141-149
44. Nakajima-Taniguchi C, Matsui H, Nagata S, Kishimoto T, Yamauchi-Takihara K (1995) Novel missense mutation in alpha-tropomyosin gene found in Japanese patients with hypertrophic cardiomyopathy. J Mol Cell Cardiol 27:2053-2058
45. Niimura H, Patton KK, McKenna WJ, Soults J, Maron BJ, Seidman JG, Seidman CE (2002) Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly. Circulation 105:446-451
46. Nishi H, Kimura A, Harada H, Harada H, Imaizumi T, Toshima H, Sasazuki T, Kimura A (1995) A myosin missense mutation, not a null allele, causes familial hypertrophic cardiomyopathy. Circulation 91:2911-2915
47. Oberst L, Ahao G, Park JT, Brugada R, Michael LH, Entman ML, Roberts R, Marian AJ (1998) Dominant-negative effect of a mutant cardiac troponin T on cardiac structure and function in transgenic mice. J Clin Invest 102:1498-1505
48. Okagi T, Weber E, Fischman DA, Vaughan KT, Mikawas T, Reinach FC (1993) The major myosin-binding domain of skeletal muscle MyBP-C (C protein) resides in the COOH-terminal, immunoglobulin C2 motif. J Cell Biol 123:619-626
49. Olson TM, Kishimoto NY, Whitby FG, Michels VV (2001) Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy. J Mol Cell Cardiol 33:723-732
50. Ortlepp JR, Vosberg HP, Reith S, Ohme F, Mahon NG, Schroder D, Klues HG, Hanrath P, McKenna WJ (2002) Genetic polymorphisms in the renin-angiotensin-aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C gene. Heart 87:270-275
51. Poetter K, Jiang H, Hassanzadeh S, Master SR, Chang A, Dalakas MC, Rayment I, Sellers JR, Fananapazir L, Epstein ND (1996) Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet 13:63-69
52. Prabhakar R, Boivin GP, Grupp IL, Hoit B, Arteaga G, Solaro JR, Wieczorek DF (2001) A familial hypertrophic cardiomyopathy alpha-tropomyosin mutation causes severe cardiac hypertrophy and death in mice. J Mol Cell Cardiol 33:1815-1828
53. Rayment I, Holden HM, Sellers JR, Fananapazir L, Epstein ND (1995) Structural interpretation of the mutations in β-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy. Proc Natl Acad Sci USA 92:3864-3868
54. Reddy DS (1997) Cellular and molecular biology of cardiac hypertrophy. Curr Science 72:13-30
55. Richard P, Isnard R, Carrier L, Dubourg O, Donatien Y, Mathieu B, Bonne G, Gary F, Charron P, Hagege M, Komajda M, Schwartz K, Hainque B (1999) Double heterozygosity for mutations in the β-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy. J Med Genet 36:542-545
56. Robinson P, Mirza M, Knott A, Abdulrassak H, Willott R, Marston S, Watkins H, Redwood C (2002) Alterations in thin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathy. J Biol Chem 277:40710-40716
57. Roopnarine O, Leinwand LA (1998) Functional analysis of myosin mutations that cause familial hypertrophic cardiomyopathy. Biophys J 75:3023-3030
58. Sadoshima J, Izumo S (1993) Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: potential involvement of an autocrine/paracrine mechanism. EMBO J 12:1681-1692
59. Sata M, Ikebe M (1996) Functional analysis of the mutations in the human cardiac beta-myosin that are responsible for familial hypertrophic cardiomyopathy. Implication for the clinical outcome. J Clin Invest 98:2866-2873
60. Satoh M, Takahashi M, Sakamoto T, Hirle M, Marumo F, Kimura A (1999) Structural analysis of the titin gene in HCM: identification of a novel disease gene. Biochem Biophys Res Commun 262:411-417
61. Schlender KK, Bean LJ (1991) Phosphorylation of chick cardiac C-protein by calcium/calmodulin-dependent protein kinase II. J Biol Chem 266:2811-2817
62. Schultheiss T, Lin ZX, Lu MH, Murray J, Fischman DA, Weber K, Masaki T, Imamura M, Holtzer H (1990) Differential distribution of subsets of myofibrillar proteins in cardiac nonstriated and striated myofibril. J Cell Biol 110:1159-1172
63. Sehnert AJ, Huq A, Weinstein BM, Walker C, Fishman M, Stainier DY (2002) Cardiac troponin T is essential in sarcomere assembly and cardiac contractility. Nat Genet 31:106-110
64. Semsarian C, Healey MJ, Fatkin D, Giewat M, Duffy C, Seidman CE, Seidman JG (2001) A polymorphic modifier gene alters the hypertrophic response in a murine model of familial hypertrophic cardiomyopathy. J Mol Cell Cardiol 33:2055-2060
65. Shimizu M, Ino H, Okeie K, Yamaguchi M, Nagata M, Hayashi K, Itoh H, Iwaki T, Oe K, Konno T, Mabuchi H (2002) Septal wall thinning and systolic dysfunction in patients with hypertrophic cardiomyopathy caused by a cardiac troponin I gene mutation. Am Heart J 143:690-695
66. Simpson PC (1988) Role of proto-oncogenes in myocardial hypertrophy. Am J Cardiol 62:13G-19G
67. Sweeney HL, Straceski AJ, Leinwand LA, Tikunov BA, Faust L (1994) Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction. J Biol Chem 269:1603-1605
68. Sweeney HL, Feng HS, Yang Z, Watkins H (1998) Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: insights into disease pathogenesis and troponin function. Proc Natl Acad Sci USA 95:14406-14410
69. Tae-Hong H, Lee W-H, Kimura A, Satoh M, Nakamura T, Kim MK, Choi SK, Park JE (1998) Early expression of a malignant pheno-type of familial hypertrophic cardiomyopathy associated with a Gly716Arg myosin heavy chain mutation in a Korean family. Am J Cardiol 82:1509-1513
70. Takahashi-Yanaga F, Morimoto S, Harada K, Minakami R, Shiraishi F, Ohta M, Lu QW, Sasaguri T, Ohtsuki I (2001) Functional consequences of the mutations in human cardiac troponin I gene found in familial hypertrophic cardiomyopathy. J Mol Cell Cardiol 33:2095-2107
71. Takai E, Akita H, Shiga N, Kanazawa K, Yamada S, Terachima M, Matsuda Y, Iwai C, Kawai K, Tokota Y, Yomoyama M (1999) Mutational analysis of the cardiac actin gene in familial and sporadic dilated cardiomyopathy. Am J Med Genet 86:325-327
72. Tanigawa G, Jarcho JA, Kass S, Solomon SD, Vosberg HP, Seidman JG, Seidman CE (1990) A molecular basis for familial hypertrophic cardiomyopathy: an alpha/beta cardiac myosin heavy chain hybrid gene. Cell 62:991-998
73. Tesson F, Dufour C, Moolman JC (1997) The influence of the angiotensin I converting enzyme genotype in familial hypertrophic cardiomyopathy varies with the disease gene mutation. J Mol Cell Cardiol 29:831-838
74. Thierfelder L, Watkins H, MacRae C, Lamas R, McKenna W, Vosberg HP, Seidman JG, Seidman CE (1994) Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 77:701-712
75. Tyska MJ, Hayes E, Giewat M, Seidman CE, Seidman JG, Warshaw DM (2000) Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy. Circ Res 86:737-744
76. Vikstrom KL, Leinwand LA (1996) Contractile protein mutations and heart disease. Curr Opinion Cell Biol 8:97-105
77. Waldmuller S, Freund P, Mauch S, Toder R, Vosberg HP (2002) Low-density DNA microarrays are versatile tools to screen for known mutations in hypertrophic cardiomyopathy. Hum Mutat 19:560-569
78. Watkins H, Rosenzweig A, Hwang DS (1992) Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 326:1108-1114
79. Watkins H, Conner D, Thierfelder J, Jarcho JA, MacRae C, McKenna WJ, Maron BJ, Seidman JG, Seidman CE (1995a) Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet 11:434-437
80. Watkins H, McKenna WJ, Thierfelder L, Suk HJ, Anan R, O'Donoghue A, Spirito P, Matsumori A, Moravec CS, Seidman JG (1995b) Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 332:1058-1064
81. Watkins H, Seidman JG, Seidman CE (1995c) Familial hypertrophic cardiomyopathy: a genetic model of cardiac hypertrophy. Hum Mol Genet 4:1721-1727
82. Watkins H, Seidman CE, Seidman JG, Feng HS, Sweeney HL (1996) Expression and functional assessment of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy. J Clin Invest 98:2456-2461
83. Wilkins BJ, Molkentin JD (2002) Calcineurin and cardiac hypertrophy: Where have we been? Where are we going? J Physiol 541:1-8
84. Witt CC, Gerull B, Davies MJ, Centneri T, Linke WA, Thierfelder L (2001) Hypercontractile properties of cardiac muscle fibers in a knock-in mouse model of cardiac myosin-binding protein-C. J Biol Chem 276:5353-5359
85. Yamauchi-Takihara K, Nakajima-Taniguchi C, Matsui H (1996) Clinical implications of hypertrophic cardiomyopathy associated with mutations in the α-tropomyosin gene. Eur J Heart 76:63-65
86. 2+ sensitization and potentiation of the maximum level of myofibrillar ATPase activity caused by mutations of troponin T found in familial hypertrophic cardiomyopathy. J Biol Chem 274:8806-8812
87. Yang Q, Sanbe A, Osinska H, Hewett TE, Klevitsky R, Robbins J (1998) A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy. J Clin Invest 102:1292-1300
88. Yang Q, Sanbe A, Osinska H, Hewett TE, Klevitsky R, Robbins J (1999) In vivo modeling of myosin binding protein C familial hypertrophic cardiomyopathy. Circ Res 85:841-847
89. Yu B, French JA, Carrier L, Jeremy RW, McTaggart DR, Nicholson MR, Hambly B, Semsarian C, Richmond DR, Schwartz K, Trent RJ (1998) Molecular pathology of familial hypertrophic cardiomyopathy caused by mutations in the cardiac myosin binding protein C gene. J Med Genet 35:205-210